Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
ALGN - Align Technology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$205.25
DETAILS
HIGH:
$235.00
LOW:
$188.00
MEDIAN:
$199.00
CONSENSUS:
$205.25
UPSIDE:
30.25%
Stock News
Align Technology Inc (ALGN) Stock Down 5.6% -- Now Undervalued? GF Score: 89/100
On August 17, 2026, Align Technology Inc (ALGN) shares fell 5.6%, bringing the current price to $171.16. The stock has experienced a 52-week range of $122.00 to
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.
Align Technology Prevails in China Patent Infringement Action Against Angelalign
Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear
Align Technology Prevails in China Patent Infringement Action Against Angelalign
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK). In September 2025, Align filed a.
Contravisory Investment Management Inc. Makes New $1.11 Million Investment in Align Technology, Inc. $ALGN
Contravisory Investment Management Inc. acquired a new stake in Align Technology, Inc. (NASDAQ: ALGN) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 6,557 shares of the medical equipment provider's stock, valued at approximately $1,106,000. Several other hedge funds
Align Technology, Inc. $ALGN Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. lessened its holdings in Align Technology, Inc. (NASDAQ: ALGN) by 36.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 631,153 shares of the medical equipment provider's stock after selling 358,235 shares during the quarter. Assenagon Asset Management
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow.
Align Technology Inc (ALGN) Stock Down 3.2% -- Now Undervalued? GF Score: 89/100
On August 06, 2026, Align Technology Inc (ALGN) shares fell 3.2% to a current price of $169.08. The stock has seen significant volatility, trading within a 52-w
California State Teachers Retirement System Has $13.59 Million Stock Holdings in Align Technology, Inc. $ALGN
California State Teachers Retirement System grew its position in shares of Align Technology, Inc. (NASDAQ: ALGN) by 21.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 79,293 shares of the medical equipment provider's stock after buying an additional 13,867 shares during
Align Technology: Attractively Valued But Growth Still Needs To Pick Up
Align Technology delivered record Q2 revenue and clear aligner volumes, with robust international growth offsetting North American stagnation. ALGN's strategy centers on expanding its digital dentistry platform, leveraging financing, lower-cost products, and ecosystem growth to drive recurring revenue. Valuation at $173 per share (15–16x forward earnings) is attractive for a market leader with high margins, net cash, and ongoing share buybacks.
First Trust Advisors LP Sells 57,392 Shares of Align Technology, Inc. $ALGN
First Trust Advisors LP lessened its holdings in Align Technology, Inc. (NASDAQ: ALGN) by 44.5% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 71,691 shares of the medical equipment provider's stock after selling 57,392 shares during the period. First Trust Advisors LP owned 0.10%
ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise
Align Technology shares rise after Q2 earnings and revenues beat estimates, fueled by record Clear Aligner shipments and wider non-GAAP margins.
ALGN Q2 Earnings Call Highlights Digital Growth Push
ALGN highlights record clear aligner volumes, digital workflow expansion and margin gains while balancing scanner pricing pressures and long-term growth plans.
Align Technology Inc (ALGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Clear Aligner Volume Amidst Market Headwinds
Revenue: Record Q2 2026 revenue of $1.06 billion, up 4.3% year-over-year.Clear Aligner Revenue: $870.9 million, up 8.2% year-over-year.Clear Aligner Volume: Rec
Align Technology, Inc. (ALGN) Q2 2026 Earnings Call Transcript
Align Technology, Inc. (ALGN) Q2 2026 Earnings Call Transcript
Align Technology (ALGN) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Align Technology (ALGN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics
LAS VEGAS & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from its 2026 Invisalign® Ortho Summit, held July 23–26, 2026 in Las Vegas. The Summit brought together more than 500 orthodontists and practice team members for an.
Align Technology (ALGN) Q2 Earnings and Revenues Top Estimates
Align Technology (ALGN) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.56 per share. This compares to earnings of $2.49 per share a year ago.
Price Targets
Align Technology price target raised to $189 from $186 at UBS
$189.00
(was $166.86)
UBS
Align Technology initiated with an Outperform at BMO Capital
$209.00
(was $174.68)
Vik Chopra
·
BMO Capital
Align Technology price target raised to $188 from $169 at Morgan Stanley
$188.00
(was $190.67)
Morgan Stanley
Align Technology price target raised to $235 from $220 at Piper Sandler
$235.00
(was $191.66)
Jason Bednar
·
Piper Sandler
Align Technology price target raised to $200 from $170 at Barclays
$200.00
(was $187.68)
Glen Santangelo
·
Barclays
Align Technology upgraded to Buy from Hold at HSBC
$200.00
(was $187.60)
Sidharth Sahoo
·
HSBC
Align Technology price target raised to $200 from $180 at Evercore ISI
$200.00
(was $176.27)
Elizabeth Anderson
·
Evercore ISI
Align Technology price target raised to $210 from $200 at Stifel
$210.00
(was $161.30)
Stifel Nicolaus
Align Technology price target raised to $200 from $181 at Wells Fargo
$200.00
(was $173.75)
Wells Fargo
Align Technology price target raised to $218 from $205 at Baird
$218.00
(was $161.30)
Robert W. Baird
Align Technology price target raised to $185 from $175 at UBS
$185.00
(was $161.30)
UBS
Align Technology price target raised to $220 from $200 at Piper Sandler
$220.00
(was $161.30)
Piper Sandler
Align Technology price target raised to $200 from $170 at Mizuho
$200.00
(was $171.49)
Steven Valiquette
·
Mizuho Securities
Align Technology initiated with an Equal Weight at Barclays
$170.00
(was $157.68)
Barclays
Stifel Reiterates Buy Rating on Align Technology (ALGN)
$200.00
(was $141.55)
Jonathan Block
·
Stifel Nicolaus
Align Technology price target raised to $170 from $160 at Evercore ISI
$170.00
(was $131.91)
Evercore ISI
Align Technology price target raised to $200 from $190 at Piper Sandler
$200.00
(was $131.91)
Jason Bednar
·
Piper Sandler
Piper Sandler on Align Technology (ALGN): 'Improvement with Breadth, Constructive View Ahead of 3Q'
$190.00
(was $135.98)
Jason Bednar
·
Piper Sandler
Align Technology price target lowered to $155 from $160 at UBS
$155.00
(was $128.43)
UBS
Align Technology price target lowered to $170 from $210 at Mizuho
$170.00
(was $125.79)
Mizuho Securities